Biotechnology and Bioprocess Engineering:BBE

The Korean Society for Biotechnology and Bioengineering (한국생물공학회)
권호 표지

Change of Insulin-like Growth Factor Gene Expression in Chinese Hamster Ovary Cells Cultured in Serum-free Media

  • Park, Hong-Woo (Department of Chemical Engineering, Hanyang Unviersity) ;
  • An, Sung-Kwan (Department of Microbial Engineering, Konkuk University) ;
  • Choe, Tae-Boo (Department of Microbial Engineering, Konkuk University)
  • Published : 2006.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Although the sera used in animal cell culture media provide the macromolecules, nutrients, hormones, and growth factors necessary to support cell growth, it could also be an obstacle to the production of recombinant proteins in animal cell culture systems used in many sectors of the biotechnology industry. For this reason, many research groups, including our laboratory, have been trying to develop serum-free media (SFM) or serum-supplemented media (SSM) for special or multi-purpose cell lines. The Chinese hamster ovary (CHO) cell, for example, is frequently used to produce proteins and is especially valuable in the large-scale production of pharmaceutically important proteins, yet information about its genome is lacking. Also, SFMs have only been evaluated by comparing growth patterns for cells grown in SFMs with those grown in SSM or by measuring the titer of the target protein obtained from cells grown in each type of medium. These are not reliable methods of obtaining the type of information needed to determine whether an SFM should be replaced with an SSM. We carried out a cDNA microarray analysis to evaluate MED-3, an SFM developed in our laboratory, as a CHO culture medium When CHO cells were cultured in MED-3 instead of an SSM, several genes associated with cell growth were down-regulated, although this change diminished over time. We found that the insulin-like growth factor (IGF) gene was representative of the proteins that were down-regulated in cells cultured in MED-3. When several key supplements - including insulin, transferrin, ethanolamine, and selenium - were removed from MED-3, the IGF expression was consistently down- regulated and cell growth decreased proportionately. Based on these results, we concluded that when an SFM is used as a culture medium, it is important to supplement it with substances that can help the cells maintain a high level of IGF expression. The data presented in this study, therefore, might provide useful information for the design and development of SFM or SSM, as well as for the design of genome-based studies of CHO cells to determine how they can be used optimally for protein production in pharmaceutical and biomedical research.

Keywords

References

  1. Gstraunthaler, G. (2003) Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20: 275-281
  2. Kwon, M. S., T. Dojima, and E. Y. Park (2003) Comparative characterization of growth and recombinant protein production among three insect cell lines with four kinds of serum free media. Biotechnol. Bioprocess Eng. 8: 142-146 https://doi.org/10.1007/BF02940270
  3. Tey, B. T. and M. Al-Rubeai (2005) Bcl-2 over-expression reduced the serum dependency and improved the nutrient metabolism in a NS0 cells culture. Biotechnol. Bioprocess Eng. 10: 254-261 https://doi.org/10.1007/BF02932022
  4. Lockhart, D. J. and E. A. Winzeler (2000) Genomics, gene expression and DNA arrays. Nature 405: 827-836 https://doi.org/10.1038/35015701
  5. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470 https://doi.org/10.1126/science.270.5235.467
  6. Ahn, S. K., T.-B. Choe, and T.-J. Kwon (2003) The gene expression profile of human umbilical vein endothelial cells stimulated with lipopolysaccharide using cDNA microarry analysis. Int. J. Mol. Med. 12: 231-236
  7. Marcotte, E. R., L. K. Srivastava, and R. Quirion (2003) cDNA microarray and proteomic approaches in the study of brain diseases: Focus on schizophrenia and Alzheimer's disease. Pharmacol. Ther. 100: 63-74 https://doi.org/10.1016/S0163-7258(03)00086-X
  8. Wlaschin, K. F., P. M. Nissom, M. L. Gatti, P. F. Ong, S. Arleen, K. S. Tan, A. Rink, B. Cham, K. Wong, M. Yap, and W. S. Hu (2005) EST sequencing for gene discovery in Chinese hamster ovary cells. Biotechnol. Bioeng. 91: 592-606 https://doi.org/10.1002/bit.20511
  9. Layzer, R. B., L. P. Rowland, and H. M. Ranney (1967) Muscle phosphofructokinase deficiency. Arch. Neurol. 17: 512-523 https://doi.org/10.1001/archneur.1967.00470290066009
  10. Canesi, L., C. Ciacci, M. Betti, and G. Gallo (2000) Growth factor-mediated signal transduction and redox balance in isolated digestive gland cells from Mytilus galloprovincialis Lam. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 125: 355-363
  11. Cormont, M. and Y. L. Marchand-Brustel (2001) The role of small G-proteins in the regulation of glucose transport. Mol. Membr. Biol. 18: 213-220 https://doi.org/10.1080/09687680110077541
  12. Dupont, J. and R. D. Le (2001) Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol. Pathol. 54: 149-154 https://doi.org/10.1136/mp.54.3.149
  13. Strobl, J. S., W. F. Wonderlin, and D. C. Flynn (1995) Mitogenic signal transduction in human breast cancer cells. Gen. Pharmacol. 26: 1643-1649
  14. Kim, J.-S., M.-K. Min, and E.-C. Jo (2001) High-level expression and characterization of single chain urokinasetype plasminogen activator (scu-PA) produced in recombinant Chinese hamster ovary (CHO) cells. Biotechnol. Bioprocess Eng. 6: 117-127 https://doi.org/10.1007/BF02931957
  15. Kao, F. T. and T. T. Puck (1968) Genetics of somatic mammalian cell, VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc. Natl. Acad. Sci. USA 60: 1275-1281
  16. Niall, H. D. M. L. Hogan, R. Sauer, I. Y. Rosenblum, and F. C. Greenwood (1971) Sequences of pituitary and placental lactogenic and growth hormones: evolution from a primordial peptide by gene reduplication. Proc. Natl. Acad. Sci. USA 68: 866-869
  17. McCarthy A. A. (2004) Elixir pharmaceuticals: targeting molecular sources of aging. Chem. Biol. 11: 733-734
  18. Voskuil, D. W., A. Vrieling, L. J. van't Veer, E. Kampman, M. A. Rookus (2005) The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. Cancer Epidemiol. Biomarkers Prev. 14: 195-203
  19. Daughaday, W. H., K. Hall, M. S. Raben, W. D. Salmon, Jr., J. L. van den Brande, and J. J. van Wyk (1972) Somatomedin: proposed designation for sulphation factor. Nature 235: 107 https://doi.org/10.1038/235107a0
  20. Rinderknecht, E. and R. E. Humbel (1978) The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 253: 2769-2776
  21. Sherr, C. J. (1993) Mammalian G1 cyclins. Cell 73: 1059-1065
  22. Oh, M.-K. D. R. Scoles, and S.-M. Pulst (2005) DNA microarray analysis of immediate response to EGF treatment in rat schwannoma cells. Biotechnol. Bioprocess Eng. 10: 444-450 https://doi.org/10.1007/BF02989827